Literature DB >> 17916434

Transcriptional complexity of the HOXA9 locus.

Relja Popovic1, Frank Erfurth, Nancy Zeleznik-Le.   

Abstract

Evolutionarily conserved HOX genes play an important role during development and hematopoiesis. HOX protein products are transcription factors whose precise mechanism of action is still poorly understood. Regulation of HOX gene expression has been the topic of various studies. While alternative splicing and alternative promoter usage have been known to increase the number of transcripts across the HOX clusters, more recently high-throughput analyses have identified a number of new coding and noncoding RNA molecules whose function is not known. Here we review the transcriptome of the most studied HOX locus, HOXA9. Strict control of HOXA9 expression has been shown to play a critical role in hematopoiesis while aberrant expression has been shown to be important to the development of leukemia. However, it is still unclear how various transcripts from this locus are regulated and what specific role(s) each one of them plays.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17916434      PMCID: PMC2268101          DOI: 10.1016/j.bcmd.2007.07.016

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  20 in total

1.  A conserved non-homeodomain Hoxa9 isoform interacting with CBP is co-expressed with the 'typical' Hoxa9 protein during embryogenesis.

Authors:  Agnès Dintilhac; Réjane Bihan; Daniel Guerrier; Stéphane Deschamps; Isabelle Pellerin
Journal:  Gene Expr Patterns       Date:  2004-03       Impact factor: 1.224

2.  Differential expression of homeobox genes in functionally distinct CD34+ subpopulations of human bone marrow cells.

Authors:  G Sauvageau; P M Lansdorp; C J Eaves; D E Hogge; W H Dragowska; D S Reid; C Largman; H J Lawrence; R K Humphries
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 11.205

Review 3.  Hox genes in vertebrate development.

Authors:  R Krumlauf
Journal:  Cell       Date:  1994-07-29       Impact factor: 41.582

Review 4.  Homeodomain proteins.

Authors:  W J Gehring; M Affolter; T Bürglin
Journal:  Annu Rev Biochem       Date:  1994       Impact factor: 23.643

5.  The transcriptome of the leukemogenic homeoprotein HOXA9 in human hematopoietic cells.

Authors:  Sheri Tinnell Dorsam; Christina M Ferrell; Glenn P Dorsam; Mika Kakefuda Derynck; Ulka Vijapurkar; Daniel Khodabakhsh; Bonnie Pau; Hillary Bernstein; Christopher M Haqq; Corey Largman; H Jeffrey Lawrence
Journal:  Blood       Date:  2003-11-06       Impact factor: 22.113

6.  Cooperative activation of Hoxa and Pbx1-related genes in murine myeloid leukaemias.

Authors:  T Nakamura; D A Largaespada; J D Shaughnessy; N A Jenkins; N G Copeland
Journal:  Nat Genet       Date:  1996-02       Impact factor: 38.330

7.  Fusion of the nucleoporin gene NUP98 to HOXA9 by the chromosome translocation t(7;11)(p15;p15) in human myeloid leukaemia.

Authors:  T Nakamura; D A Largaespada; M P Lee; L A Johnson; K Ohyashiki; K Toyama; S J Chen; C L Willman; I M Chen; A P Feinberg; N A Jenkins; N G Copeland; J D Shaughnessy
Journal:  Nat Genet       Date:  1996-02       Impact factor: 38.330

8.  The t(7;11)(p15;p15) translocation in acute myeloid leukaemia fuses the genes for nucleoporin NUP98 and class I homeoprotein HOXA9.

Authors:  J Borrow; A M Shearman; V P Stanton; R Becher; T Collins; A J Williams; I Dubé; F Katz; Y L Kwong; C Morris; K Ohyashiki; K Toyama; J Rowley; D E Housman
Journal:  Nat Genet       Date:  1996-02       Impact factor: 38.330

9.  At least three human homeoboxes on chromosome 12 belong to the same transcription unit.

Authors:  A Simeone; M Pannese; D Acampora; M D'Esposito; E Boncinelli
Journal:  Nucleic Acids Res       Date:  1988-06-24       Impact factor: 16.971

10.  Extensive polycistronism and antisense transcription in the mammalian Hox clusters.

Authors:  Gaëll Mainguy; Jan Koster; Joost Woltering; Hans Jansen; Antony Durston
Journal:  PLoS One       Date:  2007-04-04       Impact factor: 3.240

View more
  10 in total

Review 1.  MicroRNAs in leukemias: emerging diagnostic tools and therapeutic targets.

Authors:  Yousaf A Mian; Nancy J Zeleznik-Le
Journal:  Curr Drug Targets       Date:  2010-07       Impact factor: 3.465

2.  Two isoforms of HOXA9 function differently but work synergistically in human MLL-rearranged leukemia.

Authors:  Miao He; Ping Chen; Stephen Arnovitz; Yuanyuan Li; Hao Huang; Mary Beth Neilly; Minjie Wei; Janet D Rowley; Jianjun Chen; Zejuan Li
Journal:  Blood Cells Mol Dis       Date:  2012-05-25       Impact factor: 3.039

3.  Regulation of mir-196b by MLL and its overexpression by MLL fusions contributes to immortalization.

Authors:  Relja Popovic; Laurie E Riesbeck; Chinavenmeni S Velu; Aditya Chaubey; Jiwang Zhang; Nicholas J Achille; Frank E Erfurth; Katherine Eaton; Jun Lu; H Leighton Grimes; Jianjun Chen; Janet D Rowley; Nancy J Zeleznik-Le
Journal:  Blood       Date:  2009-02-02       Impact factor: 22.113

4.  Multiple promoters and alternative splicing: Hoxa5 transcriptional complexity in the mouse embryo.

Authors:  Yan Coulombe; Margot Lemieux; Julie Moreau; Josée Aubin; Milan Joksimovic; Félix-Antoine Bérubé-Simard; Sébastien Tabariès; Olivier Boucherat; François Guillou; Christian Larochelle; Christopher K Tuggle; Lucie Jeannotte
Journal:  PLoS One       Date:  2010-05-12       Impact factor: 3.240

5.  In vitro hematopoietic differentiation of mouse embryonic stem cells requires the tumor suppressor menin and is mediated by Hoxa9.

Authors:  Elizabeth Novotny; Sheila Compton; P Paul Liu; Francis S Collins; Settara C Chandrasekharappa
Journal:  Mech Dev       Date:  2009-04-22       Impact factor: 1.882

6.  MLL protects CpG clusters from methylation within the Hoxa9 gene, maintaining transcript expression.

Authors:  Frank E Erfurth; Relja Popovic; Jolanta Grembecka; Tomasz Cierpicki; Catherine Theisler; Zhen-Biao Xia; Tara Stuart; Manuel O Diaz; John H Bushweller; Nancy J Zeleznik-Le
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-15       Impact factor: 11.205

7.  Reversing HOXA9 oncogene activation by PI3K inhibition: epigenetic mechanism and prognostic significance in human glioblastoma.

Authors:  Bruno M Costa; Justin S Smith; Ying Chen; Justin Chen; Heidi S Phillips; Kenneth D Aldape; Giuseppe Zardo; Janice Nigro; C David James; Jane Fridlyand; Rui M Reis; Joseph F Costello
Journal:  Cancer Res       Date:  2010-01-12       Impact factor: 12.701

8.  The clinical significance of HOXA9 promoter hypermethylation in head and neck squamous cell carcinoma.

Authors:  Chongchang Zhou; Jinyun Li; Qun Li; Huigao Liu; Dong Ye; Zhenhua Wu; Zhisen Shen; Hongxia Deng
Journal:  J Clin Lab Anal       Date:  2019-03-06       Impact factor: 2.352

9.  DOT1L complex suppresses transcription from enhancer elements and ectopic RNAi in Caenorhabditis elegans.

Authors:  Ruben Esse; Ekaterina S Gushchanskaia; Avery Lord; Alla Grishok
Journal:  RNA       Date:  2019-07-12       Impact factor: 4.942

10.  HOXA9 Expression is Associated with Advanced Tumour Stage and Prognosis in Nasopharyngeal Carcinoma.

Authors:  Tiancong Liu; Chao Ji; Yang Sun; Weiliang Bai
Journal:  Cancer Manag Res       Date:  2021-05-21       Impact factor: 3.989

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.